Microsoft Word 02Preface doc

2)
 
Contribution to PMTCT 
The efficacy of short-course Zidovudine for the prevention of mother to child 
transmission (PMTCT) of HIV was confirmed by KEMRI in cooperation with JICA.   
As a result, it was confirmed that the transmission rate has decreased by more than 

---

 
94 
 
60% by dosing HIV infected pregnant women with Zidovudine.    Based on this result, 
Zidovudine was adopted by earlier national intervention programmes as an 
anti-retrovirus drug. 
 
3)
 
Introduction of New Diagnostic Methods 
KEMRI was the first institute to introduce CD4/CD8 counting and viral load for 
monitoring the progress of HIV-infected patients through JICA’s cooperation.  
KEMRI took part in the technical training when the MOH introduced the equipment 
for these diagnostic methods.